Hyposmia correlates with axial signs and gait disorder in Parkinson's disease: an Italian Olfactory Identification Test study.
Hyposmia
IOIT
Motor sign
Olfaction
Parkinson’s disease
Journal
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175
Informations de publication
Date de publication:
19 Mar 2024
19 Mar 2024
Historique:
received:
23
11
2023
accepted:
11
03
2024
medline:
19
3
2024
pubmed:
19
3
2024
entrez:
19
3
2024
Statut:
aheadofprint
Résumé
Olfactory dysfunction is a non-motor symptom and an important biomarker of Parkinson's disease (PD) because of its high prevalence (> 90%). Whether hyposmia correlates with motor symptoms is unclear. In the present study, we aim to investigate the relationship between olfactory impairment with both motor and non-motor features and disease variables (disease duration, stage, and severity). One-hundred fifty-four PD patients were evaluated. Odor identification ability was tested using Italian Olfactory Identification Test (IOIT). A comprehensive spectrum of motor and non-motor features was assessed. Cognitive function was investigated through MMSE. Patients were divided into 3 different clinical phenotypes using UPDRS-III: tremor-dominant type (TDT), akinetic-rigid type (ART), and mixed type (MXT). Three of the 33 IOIT items were most frequently misidentified: basil (74.3%), coffee (66.9%), and mushroom (59.6%). Hyposmia was found in 93%. Hyposmic patients were older than controls (p = 0.01). Hoehn & Yahr (H&Y) score of 2 or greater was associated with higher probability of being hyposmic (OR = 5.2, p = 0.01). IOIT score did not significantly differ between TDT, ART, and MXT of analyzed PD patients. Performance to IOIT inversely correlated with age (p < 0.01), disease duration (p = 0.01), and H&Y score of 2 or higher (p < 0.01). Clinical features that associated with higher IOIT score were freezing of gait (FOG) (p < 0.001) and camptocormia (p < 0.05). In our cohort, IOIT scores showed a positive correlation with axial motor signs, but not with non-motor symptoms. IOIT may be a useful tool not only for supporting PD diagnosis but also for providing prognostic information about motor function.
Sections du résumé
BACKGROUND
BACKGROUND
Olfactory dysfunction is a non-motor symptom and an important biomarker of Parkinson's disease (PD) because of its high prevalence (> 90%). Whether hyposmia correlates with motor symptoms is unclear. In the present study, we aim to investigate the relationship between olfactory impairment with both motor and non-motor features and disease variables (disease duration, stage, and severity).
METHODS
METHODS
One-hundred fifty-four PD patients were evaluated. Odor identification ability was tested using Italian Olfactory Identification Test (IOIT). A comprehensive spectrum of motor and non-motor features was assessed. Cognitive function was investigated through MMSE. Patients were divided into 3 different clinical phenotypes using UPDRS-III: tremor-dominant type (TDT), akinetic-rigid type (ART), and mixed type (MXT).
RESULTS
RESULTS
Three of the 33 IOIT items were most frequently misidentified: basil (74.3%), coffee (66.9%), and mushroom (59.6%). Hyposmia was found in 93%. Hyposmic patients were older than controls (p = 0.01). Hoehn & Yahr (H&Y) score of 2 or greater was associated with higher probability of being hyposmic (OR = 5.2, p = 0.01). IOIT score did not significantly differ between TDT, ART, and MXT of analyzed PD patients. Performance to IOIT inversely correlated with age (p < 0.01), disease duration (p = 0.01), and H&Y score of 2 or higher (p < 0.01). Clinical features that associated with higher IOIT score were freezing of gait (FOG) (p < 0.001) and camptocormia (p < 0.05).
CONCLUSIONS
CONCLUSIONS
In our cohort, IOIT scores showed a positive correlation with axial motor signs, but not with non-motor symptoms. IOIT may be a useful tool not only for supporting PD diagnosis but also for providing prognostic information about motor function.
Identifiants
pubmed: 38499888
doi: 10.1007/s10072-024-07462-3
pii: 10.1007/s10072-024-07462-3
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. Fondazione Società Italiana di Neurologia.
Références
Schapira AHV, Chaudhuri KR, Jenner P (2017) Non-motor features of Parkinson disease. Nat Rev Neurosci 18(7):435–450
doi: 10.1038/nrn.2017.62
pubmed: 28592904
Kalia LV, Lang AE (2015) Parkinson’s disease. Lancet 386(9996):896–912
doi: 10.1016/S0140-6736(14)61393-3
pubmed: 25904081
Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24(2):197–211
doi: 10.1016/S0197-4580(02)00065-9
pubmed: 12498954
Shill HA, Hentz JG, Caviness JN, Driver-Dunckley E, Jacobson S, Belden C et al (2016) Unawareness of hyposmia in elderly people with and without Parkinson’s disease. Mov Disord Clin Pract 3(1):43–47
doi: 10.1002/mdc3.12220
pubmed: 30363525
Lotsch J, Reichmann H, Hummel T (2008) Different odor tests contribute differently to the evaluation of olfactory loss. Chem Senses 33(1):17–21
doi: 10.1093/chemse/bjm058
pubmed: 17761724
Huisman E, Uylings HB, Hoogland PV (2008) Gender-related changes in increase of dopaminergic neurons in the olfactory bulb of Parkinson’s disease patients. Mov Disord 23(10):1407–1413
doi: 10.1002/mds.22009
pubmed: 18581481
Pearce RK, Hawkes CH, Daniel SE (1995) The anterior olfactory nucleus in Parkinson’s disease. Mov Disord 10(3):283–287
doi: 10.1002/mds.870100309
pubmed: 7651444
Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, Sterlacci W et al (2009) Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett 453(2):77–80
doi: 10.1016/j.neulet.2009.02.006
pubmed: 19356597
Harding AJ, Stimson E, Henderson JM, Halliday GM (2002) Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease. Brain 125(Pt 11):2431–2445
doi: 10.1093/brain/awf251
pubmed: 12390970
Leonhardt B, Tahmasebi R, Jagsch R, Pirker W, Lehrner J (2019) Awareness of olfactory dysfunction in Parkinson’s disease. Neuropsychology 33(5):633–641
doi: 10.1037/neu0000544
pubmed: 30945913
Stern MB, Siderowf A (2010) Parkinson’s at risk syndrome: can Parkinson’s disease be predicted? Mov Disord 25(Suppl 1):S89-93
pubmed: 20187248
Morley JF, Duda JE (2010) Olfaction as a biomarker in Parkinson’s disease. Biomark Med 4(5):661–670
doi: 10.2217/bmm.10.95
pubmed: 20945979
Tissingh G, Berendse HW, Bergmans P, DeWaard R, Drukarch B, Stoof JC et al (2001) Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 16(1):41–46
doi: 10.1002/1531-8257(200101)16:1<41::AID-MDS1017>3.0.CO;2-M
pubmed: 11215591
Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 55(2):138–142
doi: 10.1136/jnnp.55.2.138
pubmed: 1538221
pmcid: 488979
Boesveldt S, Verbaan D, Knol DL, Visser M, van Rooden SM, van Hilten JJ et al (2008) A comparative study of odor identification and odor discrimination deficits in Parkinson’s disease. Mov Disord 23(14):1984–1990
doi: 10.1002/mds.22155
pubmed: 18759360
Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38(8):1237–1244
doi: 10.1212/WNL.38.8.1237
pubmed: 3399075
Barz S, Hummel T, Pauli E, Majer M, Lang CJ, Kobal G (1997) Chemosensory event-related potentials in response to trigeminal and olfactory stimulation in idiopathic Parkinson’s disease. Neurology 49(5):1424–1431
doi: 10.1212/WNL.49.5.1424
pubmed: 9371933
Meusel T, Westermann B, Fuhr P, Hummel T, Welge-Lussen A (2010) The course of olfactory deficits in patients with Parkinson’s disease—a study based on psychophysical and electrophysiological measures. Neurosci Lett 486(3):166–170
doi: 10.1016/j.neulet.2010.09.044
pubmed: 20858529
Muller A, Reichmann H, Livermore A, Hummel T (2002) Olfactory function in idiopathic Parkinson’s disease (IPD): results from cross-sectional studies in IPD patients and long-term follow-up of de-novo IPD patients. J Neural Transm (Vienna) 109(5–6):805–811
pubmed: 12111470
Hawkes CH, Shephard BC, Daniel SE (1999) Is Parkinson’s disease a primary olfactory disorder? QJM 92(8):473–480
doi: 10.1093/qjmed/92.8.473
pubmed: 10627864
Iijima M, Kobayakawa T, Saito S, Osawa M, Tsutsumi Y, Hashimoto S et al (2008) Smell identification in Japanese Parkinson’s disease patients: using the odor stick identification test for Japanese subjects. Intern Med 47(21):1887–1892
doi: 10.2169/internalmedicine.47.1345
pubmed: 18981632
Maremmani C, Rossi G, Tambasco N, Fattori B, Pieroni A, Ramat S et al (2012) The validity and reliability of the Italian Olfactory Identification Test (IOIT) in healthy subjects and in Parkinson’s disease patients. Parkinsonism Relat Disord 18(6):788–793
doi: 10.1016/j.parkreldis.2012.03.021
pubmed: 22510205
Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51(6):745–752
doi: 10.1136/jnnp.51.6.745
pubmed: 2841426
pmcid: 1033142
Cain WS, Krause RJ (1979) Olfactory testing: rules for odor identification. Neurol Res 1(1):1–9
doi: 10.1080/01616412.1979.11739536
pubmed: 576054
Haehner A, Masala C, Walter S, Reichmann H, Hummel T (2019) Incidence of Parkinson’s disease in a large patient cohort with idiopathic smell and taste loss. J Neurol 266(2):339–345
doi: 10.1007/s00415-018-9135-x
pubmed: 30488238
Chen W, Kang WY, Chen S, Wang Y, Xiao Q, Wang G et al (2015) Hyposmia correlates with SNCA variant and non-motor symptoms in Chinese patients with Parkinson’s disease. Parkinsonism Relat Disord 21(6):610–614
doi: 10.1016/j.parkreldis.2015.03.021
pubmed: 25921825
Walker IM, Fullard ME, Morley JF, Duda JE (2021) Olfaction as an early marker of Parkinson’s disease and Alzheimer’s disease. Handb Clin Neurol 182:317–329
doi: 10.1016/B978-0-12-819973-2.00030-7
pubmed: 34266602
Masala C, Kaehling C, Fall F, Hummel T (2019) Correlation between olfactory function, trigeminal sensitivity, and nasal anatomy in healthy subjects. Eur Arch Otorhinolaryngol 276(6):1649–1654
doi: 10.1007/s00405-019-05367-y
pubmed: 30843174
Ercoli T, Masala C, Cadeddu G, Mascia MM, Orofino G, Gigante AF et al (2022) Does olfactory dysfunction correlate with disease progression in Parkinson’s disease? A systematic review of the current literature. Brain Sci 12(5):513
doi: 10.3390/brainsci12050513
pubmed: 35624900
pmcid: 9139278
Berendse HW, Roos DS, Raijmakers P, Doty RL (2011) Motor and non-motor correlates of olfactory dysfunction in Parkinson’s disease. J Neurol Sci 310(1–2):21–24
doi: 10.1016/j.jns.2011.06.020
pubmed: 21705022
Sasaki S, Horie Y (2020) Association between olfactory impairment and disease severity and duration in Parkinson’s disease. Mov Disord Clin Pract 7(7):820–826
doi: 10.1002/mdc3.13028
pubmed: 33043078
pmcid: 7534008
Roos DS, Twisk JWR, Raijmakers P, Doty RL, Berendse HW (2019) Hyposmia as a marker of (non-)motor disease severity in Parkinson’s disease. J Neural Transm (Vienna) 126(11):1471–1478
doi: 10.1007/s00702-019-02074-0
pubmed: 31515655
He R, Zhao Y, He Y, Zhou Y, Yang J, Zhou X et al (2020) Olfactory dysfunction predicts disease progression in Parkinson’s disease: a longitudinal study. Front Neurosci 14:569777
doi: 10.3389/fnins.2020.569777
pubmed: 33381006
pmcid: 7768001
Glover A, Pillai L, Dhall R, Virmani T (2021) Olfactory deficits in the freezing of gait phenotype of Parkinson’s disease. Front Neurol 12:656379
doi: 10.3389/fneur.2021.656379
pubmed: 34456839
pmcid: 8397477
Solla P, Masala C, Ercoli T, Orofino G, Loy F, Pinna I et al (2022) Olfactory impairment in Parkinson’s disease patients with tremor dominant subtype compared to those with akinetic rigid dominant subtype: a pilot study. Brain Sci 12(2):196
doi: 10.3390/brainsci12020196
pubmed: 35203959
pmcid: 8869930
Nabizadeh F, Pirahesh K, Khalili E (2022) Olfactory dysfunction is associated with motor function only in tremor-dominant Parkinson’s disease. Neurol Sci 43(7):4193–4201
doi: 10.1007/s10072-022-05952-w
pubmed: 35166976
Damholdt MF, Borghammer P, Larsen L, Ostergaard K (2011) Odor identification deficits identify Parkinson’s disease patients with poor cognitive performance. Mov Disord 26(11):2045–2050
doi: 10.1002/mds.23782
pubmed: 21638326
Fang TC, Chang MH, Yang CP, Chen YH, Lin CH (2021) The association of olfactory dysfunction with depression, cognition, and disease severity in Parkinson’s disease. Front Neurol 12:779712
doi: 10.3389/fneur.2021.779712
pubmed: 34880827
pmcid: 8645582
Antonini A, Colosimo C, Marconi R, Morgante L, Barone P, Group Ps. (2008) The PRIAMO study: background, methods and recruitment. Neurol Sci. 29(2):61–5
doi: 10.1007/s10072-008-0863-z
pubmed: 18483702
Cozac VV, Auschra B, Chaturvedi M, Gschwandtner U, Hatz F, Meyer A et al (2017) Among early appearing non-motor signs of Parkinson’s disease, alteration of olfaction but not electroencephalographic spectrum correlates with motor function. Front Neurol 8:545
doi: 10.3389/fneur.2017.00545
pubmed: 29104561
pmcid: 5655001